Authors:
Kiran Pulidindi, Ankit Gupta
Download free PDF
Capryloyl Glycine Market Size & Share 2026-2035
Report ID: GMI5431
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Immediate Delivery Available
Capryloyl Glycine Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Capryloyl Glycine Market Size
The global capryloyl glycine market was valued at USD 1.3 billion in 2025. It is projected to reach USD 2 billion by 2035, expanding at approximately 3.8% CAGR during 2026-2035.
Capryloyl Glycine Market Key Takeaways
Market Leader: Seppic led with over 18.2% market share in 2025.
Leading Players: Top 5 players in this market include Seppic, Innospec Inc., Minasolve, Galaxy Surfactants, Scimplify, which collectively held a market share of 63.2% in 2025.
Demand is concentrated in formulations that need several functions from a small ingredient set: sebum management, acidification of the skin surface, antimicrobial support, and conditioning. That combination gives capryloyl glycine a different role from a conventional preservative, particularly in acne-oriented skin care, scalp products, and deodorant systems.
Capryloyl glycine is the INCI name for N-(1-oxooctyl)glycine (CAS 14246-53-8), an N-acyl amino acid formed from glycine and a C8 fatty-acid chain. It is listed in the EU cosmetic ingredient inventory for skin conditioning, hair conditioning, and surfactant functions, and it has an active REACH registration dossier [1]European Chemicals Agency, Substance information: N-(1-oxooctyl)glycine. echa.europa.eu. The Cosmetic Ingredient Review Expert Panel found amino acid alkyl amides, including capryloyl glycine, safe in the reported cosmetic uses and concentrations when formulations are non-irritating [2]Cosmetic Ingredient Review, Safety Assessment of Amino Acid Alkyl Amides as Used in Cosmetics. cir-safety.org. This safety boundary matters commercially: the ingredient can support a reduced conventional-preservative load, but it does not eliminate the need for formulation-specific challenge testing and tolerability assessment.
The supply chain starts with caprylic-acid feedstocks, commonly derived from coconut or palm-kernel sources, and moves through acylation, purification, and conversion into powder or aqueous formats. Powder remains the established format for large-volume manufacturing; aqueous solutions address the material's pH-dependent handling and dissolution constraints. Seppic and Minasolve market high-value grades with natural-origin and regulatory documentation, while formulation patents and liquid delivery systems are increasingly important routes to differentiation [3]Seppic, LIPACIDE™ C8G product page. seppic.com.
Europe generated USD 515.8 million in 2024, followed by Asia Pacific at USD 394.4 million and North America at USD 342.1 million. Europe's lead reflects its large cosmetics production base and restrictive preservative environment. Asia Pacific's 4.20% CAGR is driven by both consumption growth and the region's importance to standard-grade supply. Latin America and the Middle East and Africa begin from smaller bases, USD 44.3 million and USD 23.6 million respectively, but are projected to expand at approximately 6.90% and 6.60% CAGR.
GMI Analyst View
The market's moderate growth rate conceals a meaningful change in how the ingredient is purchased. Capryloyl glycine is increasingly evaluated as a formulation tool rather than a single-purpose antimicrobial: a supplier that can demonstrate pH compatibility, preservation support, and suitable purity documentation can participate in product-development decisions earlier than a supplier competing only on active cost. That favors technical-service-led suppliers in European dermocosmetics and North American clean-beauty channels.
The constraint is that multifunctionality must be converted into a credible cost-in-use case. The market's largest value pool remains in skin care, where performance claims and ingredient transparency can support premium pricing, while volume-sensitive applications may continue to favor established preservation systems. Liquid formats and documented high-purity grades are therefore not merely packaging choices; they lower formulation friction and help suppliers defend value where standard powder grades face greater comparability.
Key Drivers
Clean-label reformulation and preservation-system redesign
Demand for natural-origin and traceable cosmetic inputs has moved from a branding preference to a procurement requirement in parts of the European market. The Netherlands' Centre for the Promotion of Imports from developing countries identifies sustainability documentation, organic certification, and traceability as increasingly relevant to European buyers of natural cosmetic ingredients [4]Centre for the Promotion of Imports from Developing Countries, Natural ingredients for cosmetics: market information. cbi.eu. Capryloyl glycine fits this requirement when paired with substantiated origin and certification records. For example, Seppic positions LIPACIDE C8G with vegetable-origin feedstock and natural-origin documentation, while Minasolve documents Caprocine's ISO 16128 natural-origin index,.
The commercial mechanism is preservation-system redesign. A multifunctional ingredient can support a cleaner ingredient declaration and lower reliance on selected conventional preservatives, but its value depends on the complete antimicrobial system, packaging, water activity, and product pH. This creates a pull for suppliers that can provide formulation guidance rather than an undifferentiated raw material.
Dermatological demand in acne and scalp care
Acne and scalp conditions create demand for formulations that address excess sebum and microbial balance without relying solely on aggressive cleansing. The GBD 2021 analysis reported that prevalent acne cases among people aged 10-24 rose from 132.4 million in 1990 to 184.3 million in 2021 [5]PubMed, Global, regional and national burdens of acne vulgaris in adolescents and young adults: GBD 2021 study. pubmed.ncbi.nlm.nih.gov. A 2024 systematic review and meta-analysis reported pooled global seborrheic-dermatitis prevalence of 4.38%, with higher pooled prevalence in adults. These are not direct measures of capryloyl glycine consumption, but they enlarge the addressable formulation need for oil-control and scalp-care products.
Capryloyl glycine is especially relevant where brands seek to combine sebum-management positioning with preservation support. Its commercial advantage is strongest in leave-on facial products and scalp treatments, where ingredient selection is tied to sensory performance, safety substantiation, and claims discipline. The link should remain qualified: disease prevalence supports category demand, whereas final ingredient adoption depends on product design and clinical substantiation.
Preservative restrictions and global compliance planning
European preservative rules continue to narrow formulation flexibility for several parabens. Commission Regulation (EU) No 358/2014 prohibited isopropylparaben, isobutylparaben, phenylparaben, benzylparaben, and pentylparaben in cosmetics, while Commission Regulation (EU) No 1004/2014 amended the permitted-preservatives framework for other paraben uses. In 2023, the SCCS concluded that butylparaben at the maximum permitted 0.14% concentration was not safe for children aged 0.5-10 years in combined-use exposure scenarios.
These actions do not designate capryloyl glycine as a direct replacement. Instead, they increase the value of a broader preservation toolkit, especially for brands seeking formulas that can travel across jurisdictions. Its ECHA registration and EU cosmetic-inventory status reduce one layer of documentation risk, but each finished formula still requires market-specific safety and microbiological support.
Key Restraints
Sensitization management in sensitive-skin use cases
The ingredient's safety profile is not a blanket exemption from irritation risk. A 2019 Contact Dermatitis case report documented allergic contact dermatitis attributed to capryloyl glycine, with positive patch tests at 0.5% and 1% aqueous concentrations. The CIR conclusion is similarly conditional on non-irritating formulations. These sources do not establish population incidence, but they establish a formulation risk that is relevant to the highest-value sensitive-skin, baby-care, and leave-on categories.
For buyers, the practical consequence is longer qualification work rather than automatic exclusion. Impurity control, finished-product testing, dose selection, and the surrounding preservative system become procurement criteria. Suppliers lacking robust toxicological and batch documentation can be excluded from accounts where a cosmetic product safety report requires a traceable safety file.
Cost sensitivity and substitution risk
Capryloyl glycine's economics are most challenging where formulators compare it with a single low-cost preservative rather than with the combined functions it may support. The value proposition is more persuasive when it enables a different product architecture, such as a low-preservative-load scalp treatment or a deodorant system with antimicrobial support. It is weaker in mass-market formats with little scope for a premium claim or technical-service-led reformulation.
This creates a geographic split. In Europe and North America, compliance, retailer standards, and dermocosmetic positioning can offset a higher ingredient cost. In price-sensitive portions of Asia Pacific, Latin America, and MEA, standard grades face more direct substitution pressure, even as those regions offer the strongest forecast growth. Expansion of aqueous delivery formats may reduce handling cost, but it will not remove the need to demonstrate economic value at the formula level.
GMI Analyst View
The drivers and restraints point to a qualification-led market rather than a simple ingredient-substitution cycle. Restrictions on particular parabens create an opening, but they do not guarantee conversion; formulators must still solve preservation efficacy, sensory properties, and tolerability in a finished product. The suppliers most likely to gain are those that make this validation process faster through stability data, formulation support, and consistent purity records.
Sensitive-skin risk reinforces the same conclusion. The market is unlikely to be served well by a lowest-price model in premium leave-on applications, because a documented adverse reaction can outweigh a modest raw-material saving. Conversely, cost pressure will remain decisive in mass-market formats. This leaves room for differentiated grades and application-specific formats rather than one universal commercial offer.
Capryloyl Glycine Market Segment Analysis
By form
Powder accounted for USD 900.0 million, or approximately 68.2%, of 2024 revenue and is projected to expand at approximately 3.51% CAGR. Its position reflects storage stability, familiar handling protocols, and suitability for established production lines. However, the format requires closer attention to dispersion and pH conditions during formulation.
Liquid/aqueous material represented USD 420.1 million, or approximately 31.8%, of 2024 revenue, and is projected to grow at approximately 4.36% CAGR. Minasolve's CapEasy illustrates the direction of innovation: the company markets a 30% aqueous N-acyl amino-acid solution intended for cold processing, while its patent work addresses stable aqueous solutions,. Faster growth is tied to lower process complexity for contract manufacturers and smaller formulators, not to a wholesale replacement of powder in large plants.
By purity
The ≥99% tier generated USD 957.5 million in 2024, representing approximately 72.5% of market value, and is projected to grow at approximately 3.33% CAGR. Its dominance reflects the documentation expectations of premium personal-care applications, where impurity profiles and lot consistency affect safety assessment and finished-product qualification. The 98%-99% tier, valued at USD 200.6 million, is projected to grow fastest at approximately 5.01% CAGR; the 95%-98% tier, valued at USD 162.0 million, is projected to grow at approximately 4.76% CAGR. The faster rates in the lower tiers reflect smaller starting bases and wider cost-sensitive adoption, rather than a weakening of demand for high-purity material.
By application
Skin care led the market with USD 741.5 million in 2024, or approximately 56.2% of revenue, and is projected to grow at approximately 3.47% CAGR. Anti-acne, oil-control, pH-balancing, barrier-support, anti-aging, and dermo-protective formulations are the key subapplications. The ingredient's value is most tangible in products where a pH-adjusting and antimicrobial-supporting component can also reinforce the product's oil-control positioning.
Hair care and scalp treatment accounted for USD 278.3 million, or approximately 21.1%, of 2024 revenue, with an approximately 3.39% CAGR outlook. Anti-dandruff, anti-seborrheic, scalp-soothing, and conditioning formats link the ingredient to a scalp-care category shaped by chronic flaking and oil-control concerns. This is a technically demanding use case: efficacy positioning needs to be matched with acceptable scalp feel and preservation performance in surfactant-rich systems.
Antiperspirant and deodorant generated USD 209.4 million in 2024 and is projected to expand at approximately 4.61% CAGR. In aluminum-free deodorants, capryloyl glycine can be positioned as part of an odor-control system rather than as a sweat-suppression active. Wound care and medical topicals, valued at USD 63.9 million, are forecast to grow fastest at approximately 6.39% CAGR. Their small base should not obscure a higher barrier to entry: medical-adjacent use requires more rigorous quality and application substantiation than cosmetic use. Oral care remained the smallest application at USD 27.0 million and is projected to grow at approximately 2.57% CAGR, constrained by formulation compatibility with fluoride salts, abrasives, and flavor systems.
By distribution channel
Specialty chemical distributors represented USD 553.1 million, or approximately 41.9%, of 2024 revenue and are projected to grow at approximately 4.04% CAGR. Their relevance comes from technical support, small-volume availability, regulatory-document handling, and multi-ingredient sourcing. Direct sales accounted for USD 503.8 million, or approximately 38.2%, and are expected to grow at approximately 3.32% CAGR, reflecting established supplier relationships with larger personal-care manufacturers.
Online B2B platforms generated USD 155.1 million in 2024 and are projected to grow at approximately 5.55% CAGR. Their role is most consequential for smaller formulators that need to compare grades, documentation, and minimum order quantities. Other channels accounted for USD 108.0 million and are projected to grow at approximately 1.61% CAGR.
GMI Analyst View
Segment growth favors suppliers that can reduce the cost of formulation complexity. Aqueous material grows faster because it can shorten dispersion and process-development work, whereas powder retains its advantage where plants already have proven handling systems. The commercial contest is consequently less about format share alone than about who can help customers move from laboratory trial to reproducible production.
Application economics also diverge sharply. Skin care remains the volume anchor, but wound care and medical topicals offer a faster-growing, documentation-intensive route where cosmetic-grade price competition is less decisive. The 98%-99% purity tier's faster projected growth suggests a middle ground for customers balancing certification requirements with cost; it does not displace the ≥99% tier's importance in premium leave-on formulations.
Capryloyl Glycine Market Regional Analysis
North America
North America generated USD 342.1 million in 2024 and is projected to reach USD 465.1 million by 2035, at approximately 2.82% CAGR. The U.S. is the principal market, supported by premium skin care, retailer clean-ingredient programs, and direct technical engagement between ingredient suppliers and large brand owners. Growth is slower than in emerging regions because clean-label reformulation is already more advanced in many premium accounts. Canada contributes through a similar premium personal-care orientation and cross-border supply chains.
Europe
Europe led with USD 515.8 million in 2024 and is projected to reach USD 761.3 million by 2035, at approximately 3.60% CAGR. The region combines a large cosmetics base with a regulatory setting that makes preservative selection a product-development issue. Cosmetics Europe reported EUR 104 billion in European cosmetics and personal-care retail sales in 2024; Germany, France, Italy, the UK, and Spain were the largest national markets in the supplied regional scope [6]Cosmetics Europe, Annual Report 2024. cosmeticseurope.eu. Germany, UK, France, Spain, Italy, and the Rest of Europe therefore provide both volume and a demanding qualification environment. France is especially important as a production and innovation center for premium ingredient suppliers.
Asia Pacific
Asia Pacific recorded USD 394.4 million in 2024 and is projected to reach USD 620.1 million by 2035, at approximately 4.20% CAGR. China combines standard-grade manufacturing capacity with a growing premium cosmetics market. India offers a large skin-care demand base; the GBD 2021 study identified India and China as the countries with the largest numbers of prevalent acne cases in the 10-24 cohort. Japan and South Korea support high-value dermocosmetics and minimalist formulation concepts, while Australia adds a mature premium market. The Rest of Asia Pacific provides further growth through urban consumer markets and expanding distributor networks.
Latin America
Latin America generated USD 44.3 million in 2024 and is forecast to reach USD 93.4 million by 2035, at approximately 6.90% CAGR. Brazil is the regional anchor; ABIHPEC identifies it as one of the world's largest personal-hygiene, perfumery, and cosmetics consumer markets. Mexico and the Rest of Latin America provide additional opportunities as digital sourcing and distributor coverage widen access for regional formulators. The high forecast rate reflects underpenetration and a low starting base, so suppliers need cost-sensitive grades and local technical support rather than assuming premium European product propositions will transfer unchanged.
Middle East and Africa
The Middle East and Africa market was valued at USD 23.6 million in 2024 and is projected to reach USD 47.7 million by 2035, at approximately 6.60% CAGR. Saudi Arabia, UAE, and South Africa are the principal named markets, supported by premium beauty spending, urbanization, and expanding digital retail. The Rest of Middle East and Africa adds a fragmented, distributor-led opportunity. The region's growth is commercially attractive but operationally demanding because buyer requirements and regulatory pathways vary materially across countries.
GMI Analyst View
Europe and Asia Pacific carry different forms of strategic importance. Europe provides the deepest regulatory and premium-formulation demand, rewarding suppliers that can support claims, safety files, and certification. Asia Pacific is both a demand engine and a supply center, making specification control and supplier differentiation particularly important as standard-grade availability expands.
Latin America and MEA offer the highest forecast CAGRs, yet their commercial pathway is not a replica of the European model. Distribution reach, smaller order sizes, and formula-level economics will shape adoption more than prestige positioning alone. A two-track strategy is therefore indicated: protect technical value in mature premium regions while building accessible channel coverage and application support in high-growth, lower-penetration markets.
Capryloyl Glycine Market Share & Competitive Landscape
The market is moderately concentrated among premium suppliers and more fragmented in standard-grade material. Seppic holds approximately 18.2% of 2024 revenue, followed by Innospec Inc. at approximately 15.0%, Minasolve at approximately 12.0%, Galaxy Surfactants at approximately 10.0%, and Scimplify at approximately 8.0%. Together, these five suppliers account for approximately 63.2% of market revenue. Their competitive positions differ: premium producers emphasize natural-origin credentials, technical documentation, and application support, whereas platform and distributor models broaden access for smaller customers.
Seppic markets LIPACIDE C8G, a capryloyl glycine product positioned for skin care, scalp care, and deodorant applications, with vegetable-origin and certification documentation. Innospec Inc. participates through its personal-care surfactant and glycinate portfolio, using broader formulation relationships to support sales [7]Innospec, Glycinates product range. innospec.com. Minasolve offers Caprocine powder and CapEasy aqueous material, linking its position to liquid-format innovation and patent-protected solution technology,. Galaxy Surfactants participates through Galguard Trident, a preservation blend containing capryloyl glycine; its specialty-care strategy and capacity investment strengthen its ability to serve expanding personal-care demand,. Scimplify is positioned around digital specialty-chemical sourcing, aligned with the growth of online B2B procurement.
The remaining authorized participants serve differentiated regional, digital, and specialty roles: ATAMAn KIMYA, Pinpools GmbH, Euro-Kemical SRL, Sinerga S.p.A., AE Chemie, DRAVYOM Chemical Company, DropBio, Uniproma, Special Chem, Zley Group, and Euro-Kemical. Euro-Kemical supplies capryloyl glycine to cosmetic formulators, while Uniproma markets PromaCare® CAG for cosmetic applications. AE Chemie markets C8G with clean-beauty retailer compatibility information. Across this group, commercial differentiation depends on the ability to provide dependable technical documentation, compatible formats, and localized access rather than on the active molecule alone.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →